VANGUARD GROUP INC - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 54 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$16,887,364
+17.0%
1,474,879
+5.1%
0.00%
Q2 2023$14,432,781
+36.5%
1,403,967
+2.5%
0.00%
Q1 2023$10,574,154
+5.7%
1,369,709
+0.7%
0.00%
Q4 2022$9,999,697
+23.7%
1,360,503
+21.2%
0.00%
Q3 2022$8,084,000
+50.8%
1,122,800
+78.3%
0.00%
Q2 2022$5,359,000
-15.6%
629,773
-11.0%
0.00%
Q1 2022$6,347,000
-34.3%
707,598
+1.4%
0.00%
Q4 2021$9,664,000
+56.0%
697,754
+20.2%
0.00%
Q3 2021$6,194,000
+19.7%
580,478
+0.9%
0.00%
Q2 2021$5,176,000
-15.1%
575,217
-0.0%
0.00%
Q1 2021$6,099,000
-11.6%
575,343
+5.1%
0.00%
Q4 2020$6,900,000
+147.8%
547,643
+72.8%
0.00%
Q3 2020$2,785,000
+53.4%
316,891
+69.4%
0.00%
Q2 2020$1,816,000
+237.5%
187,0430.0%0.00%
Q1 2020$538,000
-25.1%
187,0430.0%0.00%
Q4 2019$718,000
-2.0%
187,0430.0%0.00%
Q3 2019$733,000
-14.1%
187,043
-7.7%
0.00%
Q2 2019$853,000
+2.9%
202,582
+67.7%
0.00%
Q1 2019$829,000
+88.0%
120,782
+0.8%
0.00%
Q4 2018$441,000
-69.4%
119,782
-47.4%
0.00%
Q3 2018$1,442,000
-12.1%
227,834
+5.2%
0.00%
Q2 2018$1,640,000
-7.7%
216,634
-2.4%
0.00%
Q1 2018$1,776,000
-18.6%
222,021
+14.0%
0.00%
Q4 2017$2,182,000
+23.5%
194,831
+27.9%
0.00%
Q3 2017$1,767,000152,3270.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$32,400,0002.50%
Omega Fund Management, LLC 1,284,900$16,190,0002.43%
Avidity Partners Management LP 1,248,000$15,725,0000.51%
Samsara BioCapital, LLC 399,190$5,030,0000.51%
EcoR1 Capital, LLC 741,290$9,340,0000.50%
DAFNA Capital Management LLC 113,202$1,426,0000.42%
TIGER MANAGEMENT L.L.C. 137,728$1,735,0000.39%
Orbimed Advisors 3,070,955$38,694,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 198,260$2,498,0000.22%
Artal Group S.A. 593,030$7,472,0000.16%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders